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In response to the programmatic and policy issues arising from the conflicting evidence 
concerning interactions between hormonal contraception and HIV acquisition, Population 
Council and Marie Stopes International convened a symposium to review and discuss the 
critical and emerging issues around integrating SRH and HIV and AIDS services, to enable 
dual protection. 
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BACKGROUND AND MEETING OBJECTIVES 
 To provide a framework for thinking about policy development, implementation guidance and development 
of innovative interventions to strengthen dual/multiple protection strategies 
 To present an overview of evidence around HIV acquisition and hormonal contraception to frame policy 
considerations to be discussed at the WHO technical consultation 
 
Engendering linkages between sexual and reproductive health (SRH) and HIV and AIDS, especially through 
integrating services, has received strong support and political commitment globally. Over the past decade, strategies 
have been developed to integrate various HIV and AIDS prevention and treatment services with a variety of SRH 
services, notably maternal health and family planning services. However, the evidence base available to guide 
programming remains limited. Strategies for enabling women and couples to protect themselves against both an 
unintended pregnancy and a sexually transmitted infection received considerable attention immediately after the 
1994 Cairo International Conference on Population and Development and early in the HIV epidemic, but the 
development of dual protection strategies has not progressed much beyond promoting consistent condom use. 
The objectives of this one-day symposium were to review and discuss critical and emerging issues around 
integrating SRH and HIV and AIDS services to enable dual protection, including new directions in dual protection 
technology and behaviour change interventions. The meeting also provided an opportunity to discuss the 
programmatic and policy issues arising from the conflicting evidence concerning interactions between hormonal 
contraception and HIV acquisition. Overview presentations were given by John Townsend (Vice President for 
Reproductive Health, Population Council), Ian Askew (Co-Director, Strengthening Evidence for Programming on 
Unintended Pregnancy [STEP UP] Research Consortium, Population Council) and Heidi Quinn (Technical Adviser, 
Strengthening International Family Planning Organisations Programme, Marie Stopes International) to set the scene 
for discussions, providing a framework for thinking about policy development and implementation guidance to 
strengthen dual/multiple protection. Lunch time guest presentations were made by Susannah Mayhew and Kathryn 
Church (London School of Hygiene and Tropical Medicine) that presented key findings from a large-scale 
operations research programme that is testing and evaluating alternative models for integrating SRH and HIV 
services. 
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SESSION ONE:  THE NET CONTRIBUTION OF HORMONAL CONTRACEPTION: 
UNINTENDED PREGNANCIES AND THE RISK OF HIV TRANSMISSION 
 
Body of evidence on hormonal contraception and HIV, biological mechanisms, 
and trade-offs of withdrawing DMPA and HIV infection, unintended 
pregnancies, maternal mortality, delivery options for hormonal contraception  
 
John Townsend from Population Council delivered a presentation entitled ―Competing risks of unintended 
pregnancy and HIV acquisition”. Looking at the Heffron et al. (2011) study, ―Use of hormonal contraceptives and 
risk of HIV-1 transmission: a prospective cohort study”, Townsend discussed possible mechanisms for HIV 
acquisition (male to female) with hormonal contraception. These included: 
 
1. Transfer across intact or disrupted vaginal or cervical epithelium (direct infection), including through 
abrasions 
2. Modification of the epithelial ―barrier‖ by hormones 
3. Upward transfer in cervical mucus 
4. Increased risk of transfer during bleeding 
5. Disturbed vaginal and cervical immunology 
6. Acquisition of other STIs increasing risk. 
 
The limitations of studies generating this evidence include co-infections, change in immunology and changes over 
the menstrual cycle. While there is evidence of increased viral shedding, this is still difficult to understand. The 
possibility of selection bias was mentioned, as was the fact that the hormonal contraception dosage was 
undisclosed. In summary, the biomedical mechanisms through which use of hormonal contraception would increase 
the risk of HIV acquisition remain unproven because of inconclusive evidence. Townsend presented the difficult 
choices faced by service users for dual protection goals (against infectious disease and unwanted pregnancy), and 
challenges faced by policy makers in determining programming and funding interventions. 
 
The conclusive message remains the additional use of condoms with all other forms of contraception for dual 
protection. 
 
Choices for Individuals:  
 Sterilization, IUD, and implants better than DMPA;  
 DMPA better than oral, condom, or no method 
 
Public Policy Options:  
 Withdrawal of DMPA not warranted;  
 Randomised controlled trial neither feasible nor ethical; 
 Need to repeat analyses for other contexts 
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The presentation ended with the following key questions: 
 
1. Does it make sense to change WHO Medical Eligibility Criteria for hormonal products? 
2. Should procurement and counselling policies be reviewed, in what contexts? 
3. How should international organisations engage in this debate? 
 
The plenary discussion began with the question of the HIV transmission mechanism. While there may be potential 
for increased transmission due to hormonal contraception use, there has not been enough evidence to determine 
how this might occur. The focus so far has been on cases that have a much larger impact, for example, abrasions. 
More robust measures and analysis of condom use are needed. 
 
The need for improved messaging around dual protection from a policy perspective was emphasised. Discordant 
couples may receive more counselling, or orientation, which may lead to a higher reported dual use. It was agreed 
that there is very little evidence relating to our understanding of the acceptability of dual protection and related 
behaviours. It was noted that dual protection is a service provision ―mantra‖, but that there is no clarity over what this 
actually means. The possibility of a randomised control trial was discussed; however, due to the likely costs its 
feasibility is in doubt. 
 
The issue of counselling was discussed extensively, focussed not on communicating how hormonal contraception 
may affect HIV transmission, but rather on how to ensure that couples know who is positive and counsel accordingly. 
WHO‘s Medical Eligibility Criteria were discussed with the conclusion, subsequently confirmed at the WHO meeting, 
that they are not changing, but have added an addendum. Extra advice would be more around programming and 
counselling – towards method mix, dual protection, risk assessment, and country profile. 
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SESSION 2A: WHAT CAN WE DO RIGHT NOW TO ENHANCE DUAL 
PROTECTION? 
Proven approaches to program integration: Focus on reproductive rights, 
balanced counselling, improved availability of more methods, re-position condom 
 
Ian Askew from Population Council delivered a presentation on Dual Protection. Askew began by presenting the 
UK government perspective – one that is supportive of greater integration and linkage between SRH and HIV. The 
rationale for linking the two focuses on the evidence that the majority of HIV infections in developing countries are 
sexually transmitted or associated with pregnancy, childbirth and breastfeeding.  
Some common determinants of unintended pregnancy and vulnerability to infection cited were:  
 Poverty 
 Gender inequality 
 Gender-based violence 
 Human rights violations 
 Marginalisation of key populations 
 Stigma and discrimination. 
 
A greater push is needed to develop stronger linkages between SRH and HIV. However, there are concerns around 
the potential cost of such strategies, and the potential diversion of resources into less effective interventions. There 
are also concerns regarding stigmatisation and reduced service quality. 
Issues around linkage include the lack of systematic documentation on intervention effectiveness and integration and 
the lack of evidence on resource requirements. Overall there is a lack of rigorous research and intervention 
evaluations. 
 
A rights-based approach is essential, and any dual protection strategy has to be determined by individual rights and 
needs. Each situation has a different frame of reference for the individual women and a desired impact for the 
service delivery model trying to meet her needs. 
 
It is important to remember that while condoms are a technology, they require a behaviour in order to be effective. It 
is necessary to move away from a focus on a purely technological ―fix‖ and towards behavioural considerations in 
technology use, as even a highly effective technology can fail without the correct behaviour.  It was agreed that job 
aides can be useful, helping providers to overcome bias. Providing information and services simultaneously is 
usually preferred, although referrals can work and in some situations are preferable. 
Questions around reaching those clients outside the formal health system were raised, and the importance of looking 
at alternatives from a programming point of view emphasised. The presentation concluded with the following 
discussion points: 
1. How to ensure that girls and women can access and benefit from the new technologies? 
2. How to maximise and sustain their effectiveness when used or implemented? 
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SESSION 2B: EXPERIENCES FROM SERVICE DELIVERY 
Integrating services and choices: The MSI experience 
 
Heidi Quinn from MSI delivered the next presentation, addressing the programmatic challenges of integrating 
HIV and SRH services, and the re-integration of HIV into SRH care. Quinn suggested that MSI has been more 
effective with delivering FP services, but less so with HIV services. MSI country programmes are dependent not only 
on policies and support from headquarters, but also on the interest and expertise of the individual MSI country 
programmes, and on donor funding and policy support and resources available.  
Implications for MSI from the Heffron et al. study: 
The international community response was viewed as relatively balanced. MSI sent advice and guidance to partner 
programmes following national media coverage of the study in several countries, emphasising the need to maintain a 
comprehensive family planning method mix and emphasizing dual protection. This message was also communicated 
with external MSI partners and donors. Anecdotally, at a programme level there appears to be no decrease in 
demand for injectables and very few client-led enquiries into the issue.  
MSI is currently assessing and re-emphasising integration in its service delivery programmes. MSI has looked at the 
best way of bundling services together depending on the setting. For example, in South Africa this may be VCT with 
safe abortion, in Kenya STI screening is offered for male circumcision and family planning clients and in Vietnam it is 
cervical screening. MSI has also targeted male circumcision programmes in Zambia and Malawi, with the aim of 
linking the entry point of men into SRH, family planning and HIV testing. 
MSI is also developing a new Management Information System (MIS) which will enable better linkage of the client 
and the services they receive in order to be able to look at the integration of services and an improved ability to 
include consideration of the profile of its clients. MSI‘s USAID-funded Strengthening International Family Planning 
Organizations (SIFPO) project is working with Population Council, HIV/AIDS Alliance, EngenderHealth and the 
International Centre for Research on Women on appropriate integration of services with family planning, and for 
special groups such as youth and PLWHA. 
Through an ―HIV-SRH integration tool‖ developed by the HIV/AIDS Alliance, MSI Partners will be able to examine 
the level and quality of their integration. As part of the tool there will be a recommendation of a minimum level of 
integration that all MSI partners should be offering; what they could be offering above this will depend on the 
prevalence and drivers of the epidemic. Whether MSI‘s partners should aim to serve the general population with 
comprehensive integrated services or offer targeted services to most-at-risk groups will depend on the national 
situation. 
Future improvements will include ensuring measurement of integration in a logical way. Implications of the Heffron et 
al. study on service provision will depend on whether WHO changes its guidance, but MSI would like to train 
providers to better discuss and assess risk with clients to inform their SRH choices. The ability of the provider to 
discuss health issues is critical for the assessment of individual needs. However, multiple variables may affect the 
client‘s disclosure of HIV status, reproductive desires and lifestyle, while the national health environment and 
services also affect clients‘ risk factors. Rural clients and providers, where the choice of methods and services may 
not be optimal, must be taken into account when making a policy assessment and must be advised accordingly. Key 
challenges for MSI include the location of integration services and commodity security. 
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The plenary session began with the challenge of reform. Some of the biggest obstacles to service delivery include 
the discussion regarding full or partial integration. A significant concern is the present lack of female condoms being 
on the agenda and the poor promotion of dual protection. 
The importance of rigorous evidence, including through systematic reviews of the effectiveness of integration 
interventions, was stressed, while acknowledging that determinants outside the health system are also critical. It was 
suggested that the evidence base around structural determinants of HIV is weak and there is little information 
regarding social determinants of dual protection. 
Counselling was an issue that arose consistently, with the point made that there have been very few interventions 
aimed at increasing dual protection. 
 The question of access was raised in terms of where clients can access stigma-free client-friendly services. 
Vulnerable clients may not always want to be referred as they would often rather have a one-stop shop. 
  
  
 
Page 6 
LUNCH AND GUEST PRESENTATIONS 
INTEGRA: A LARGE-SCALE STUDY TO DETERMINE THE IMPACT OF SRH-HIV 
INTERVENTIONS 
Assessing integrated SRH and HIV services in Kenya, Swaziland and 
Malawi 
Susannah Mayhew introduced the INTEGRA project, a collaboration between International Planned Parenthood 
Federation, London School of Hygiene and Tropical Medicine and Population Council in Kenya, Swaziland and 
Malawi, with the objectives of determining the benefits from different integrated models, the impact of different 
integrated services on HIV risk and fertility behaviours, the efficiency of different operational models, and utilization 
of the research findings by policy and program decision makers. Mayhew discussed the characteristics of the four 
integration models being piloted in Kenya and Swaziland and the range of research methods associated with the 
evaluations, including facility assessments, community surveys, cohort surveys, cross-sectional surveys and 
economic analyses. 
Challenges include the complex implementation environment in all countries and marrying the rigorous multi-method 
evaluation research approach with the ‗reality‘ of large-scale delivery of integrated HIV and SRH services. 
Measuring unmet need for dual protection in Kenya: An analysis of 
community survey and family planning client cohort datasets  
Kathryn Church delivered the second presentation from INTEGRA. Church presented the background to the study, 
discussing the current lack of standardised methods for measuring unmet need for dual protection. Church explained 
the methodology and discussed the definitions of the terms ‗unmet need for FP‘ and ‗unmet need for HIV prevention‘. 
Those ‗at risk‘ include clients who have attended STI services within the past 12 months, and/or those who have 
attended HIV care, or their partner has in the past 12 months, or those with more than one current sexual partner, or 
those who have never had an HIV test or do not know their status.  
Church then discussed the ‗risk profile‘ and determinants of unmet needs (for family planning and prevention). A ‗risk 
profile summary‘ identified those with increased odds of unmet needs. Findings include the fact that a high 
proportion of women are at risk for unmet need for FP, with a lower proportion at risk for STIs, while the proportion at 
risk for both is lower still. More specifically: 
Those at risk for unmet need for FP include those with the following characteristics: younger, not married, have 
secondary education, not the main earner, never had HIV test. 
Those at risk for unmet need for prevention include those with the following characteristics: older, married, lower 
SES, nulliparous, have more sex partners, not been for FP services in past year 
Church also looked at the characteristics of those FP clients with an unmet need for prevention. These include: 
married, lower education, Christian, manual workers, medium income, different fertility desires to partner, have more 
children, are HIV-negative or unknown status. 
Limitations to the study include the crude estimates of unmet need due to weaknesses in measuring type of 
contraception used and consistency of condom use. Differences in indicator variables across surveys also make 
direct comparisons challenging. Further analysis is required to tease out potential effect modification.  
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SESSION 3: FUTURE INVESTMENTS IN IMPROVING DUAL PROTECTION 
INTERVENTIONS 
Dual protection products and technology (Naomi Rutenberg)   
 
In Naomi Rutenberg’s absence, John Townsend delivered a presentation on future investments in improving 
dual protection interventions. Beginning with summarising the magnitude of the need for dual protection, the 
scope of dual protection technologies with regards to reducing risks of unintended pregnancy and HIV acquisition 
was considered in terms of technical feasibility, safety and acceptability. 
Townsend noted the ARV-based products currently in development for HIV prevention, and then explained what is in 
the pipeline for dual protection. These include USAID-supported initiatives:  
 90-day combination vaginal ring with TFV and LNG (CONRAD) 
 60-day combination vaginal ring with  a hormonal contraceptive (tbd) and dapivirine (IPM) 
 Pericoital vaginal gel with MIV-150, Zn-acetate, carrageenan and LNG (Population Council) 
 SILCS diaphragm with TFV gel –barrier device + drug (CONRAD, PATH). 
 
And others including: 
 Ferrous gluconate with AZT IVR (Weil MC, Cornell) 
 Praneem polyherbal tablet (NARI, India) 
 New versions of male and female condoms. 
 
The non-hormonal contraceptive options were then discussed, and the question arose as to whether they can be 
paired with HIV prevention strategies. Barrier drug combinations and other options were looked at. Safety issues for 
both contraceptive products and HIV prevention options were examined next. While ARV-based HIV prevention 
strategies have raised concern over the emergence of resistance, specific ARV-based strategies have known safety 
side effects, including effects on bone density and kidneys. Technical feasibility options and challenges were 
discussed, although the regulatory path remains unknown. 
Discussion questions began with the main acceptability and compatibility challenges. Questions included the 
compatibility of dual protection products with current service delivery strategies for family planning.  Also raised was 
the issue of how routine HIV testing might be incorporated into family planning service provision. Final thoughts 
focused on what it would take to introduce the proposed formulations/delivery systems to users and providers in Sub 
Saharan Africa. 
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CONCLUDING GROUP DISCUSSION 
What actions and investments are needed in research, policy guidance and 
implementation programming?  
 
Tania Boler opened by summarising the Symposium recommendations. First, to look at the implications from the 
consensus body of evidence around hormonal contraception and HIV acquisition, with the recommendation of no 
policy change. For key populations, the recommendation would be to manage the provision and correct, consistent 
use of condoms. As one of a series of studies reporting the relationship between hormonal contraception and HIV 
acquisition, the Heffron et al. study must be put into context given the conflicting findings. 
The issue of counselling is not clear-cut, in particular for frontline providers around combining advice and guidance 
on HIV prevention and avoiding unintended pregnancy, in particular the capacity to understand and communicate 
the nuanced risk and complex tradeoffs. Future investments include those around structure, technology and 
behaviour. New ways of providing the counselling were debated, and solutions included social marketing, media, 
and information dissemination. The issue of provider bias was raised. The importance of tools allowing a provider to 
assess risk quickly was emphasised. Text messaging through eHealth and mHealth can be an effective method of 
communication and assessment. 
Further points discussed were focussed around operations research, and the need for qualitative research to better 
understand the behaviour of those regularly using dual protection.  The changing landscape of HIV prevention, with 
male circumcision now a factor, was also raised. Finally, the group discussed the cost efficiency of integrated 
programming and the potential for undertaking research to look at cost efficiencies. 
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AGENDA 
Objectives:  
1. Provide a framework for thinking about policy development, implementation guidance and development of 
innovative interventions to strengthen dual/multiple protection strategies 
2. Present an overview of evidence around HIV acquisition and hormonal contraception to frame policy 
considerations to be discussed at the WHO technical consultation 
3. Generate recommendations for research and evidence strengthening 
 
Time Title Presenter 
10.30 – 11.00 
 
Introduction and overview 
 
Michael Holscher and 
Patricia Atkinson 
11.00 – 12.00 
(moderated 
discussion) 
 
Session 1: The net contribution of hormonal contraception: 
unintended pregnancies and the risk of HIV transmission  
Body of evidence on hormonal contraception and HIV, biological 
mechanisms, and trade-offs of withdrawing DMPA and HIV infection, 
unintended pregnancies, maternal mortality, delivery options for 
hormonal contraception 
John Townsend 
 
12.00 – 13.00 
 
Session 2a: What we can do right now to enhance dual 
protection? 
Proven approaches to program integration: Focus on reproductive 
rights, balanced counselling, improved availability of more methods, 
re-position condom 
Session 2b: Experiences from service delivery 
Integrating Services & Choices: The MSI Experience 
Ian Askew 
 
 
 
Heidi Quinn 
13.00 – 13.30 
 
Lunch and guest presentation: 
INTEGRA: A large-scale study to determine the impact of FP-HIV 
interventions 
Susannah Mayhew 
and Kathryn Church 
(LSHTM) 
13.30 – 14.30 
(moderated 
discussion) 
Session 3: Future investments in improving dual protection 
interventions 
Dual protection products and technology 
Naomi Rutenberg 
14.30 – 15.00 Concluding group discussion: What actions and investments are 
needed in research, policy guidance and implementation 
programming?  
Tania Boler 
Symposium moderator:  Emma Simpson 
